Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Shares Outstanding (2016 - 2025)

Tandem Diabetes Care's Shares Outstanding history spans 13 years, with the latest figure at $68.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 3.06% year-over-year to $68.3 million; the TTM value through Dec 2025 reached $68.3 million, up 3.06%, while the annual FY2025 figure was $68.3 million, 3.06% up from the prior year.
  • Shares Outstanding reached $68.3 million in Q4 2025 per TNDM's latest filing, up from $67.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $68.3 million in Q4 2025 to a low of $62.6 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $65.1 million, with a median of $64.8 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: increased 4.16% in 2021, then decreased 0.07% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $63.8 million in 2021, then grew by 1.07% to $64.5 million in 2022, then rose by 1.61% to $65.6 million in 2023, then grew by 1.09% to $66.3 million in 2024, then rose by 3.06% to $68.3 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Shares Outstanding are $68.3 million (Q4 2025), $67.8 million (Q3 2025), and $67.5 million (Q2 2025).